These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULE 14A
|
|
NMI Holdings, Inc.
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
5)
|
Total fee paid:
|
|
|
1)
|
Amount previously paid:
|
|
|
2)
|
Form, Schedule, or Registration Statement No.:
|
|
|
3)
|
Date Filed:
|
|
|
1.
|
the election of seven directors to the board of directors to serve until the 2019 Annual Meeting of Stockholders;
|
|
2.
|
the ratification of the appointment of BDO USA, LLP as NMI's independent registered public accounting firm for the year ending December 31, 2018; and
|
|
3.
|
any other matters that properly come before the Annual Meeting.
|
|
ABOUT THE ANNUAL MEETING AND PROXY STATEMENT
|
1
|
|
|
ITEM 1 - ELECTION OF DIRECTORS
|
5
|
|
|
CORPORATE GOVERNANCE AND BOARD MATTERS
|
9
|
|
|
EXECUTIVE OFFICERS
|
15
|
|
|
COMPENSATION OF NAMED EXECUTIVE OFFICERS
|
16
|
|
|
BENEFICIAL OWNERSHIP OF COMMON STOCK
|
36
|
|
|
ITEM 2 - RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
39
|
|
|
APPENDIX A - EXPLANATION AND RECONCILIATION OF OUR USE OF NON-GAAP FINANCIAL MEASURES
|
i
|
|
|
FORM OF PROXY CARD
|
|
|
|
•
|
possess fundamental qualities of intelligence, honesty, perceptiveness, good judgment, maturity, high ethics and standards, integrity, fairness and responsibility;
|
|
•
|
maintain a genuine interest in the Company and recognize that as a member of the Board he or she is accountable to the stockholders of the Company and not to any particular interest group;
|
|
•
|
have financial services or other relevant industry experience gained through senior management or board of director service;
|
|
•
|
have prior board experience, either as a director of a public company or as both an executive officer of a public company and a director of a privately held company;
|
|
•
|
not serve on more than three other boards of directors of public companies;
|
|
•
|
meet the independence requirements under NASDAQ listing requirements (other than any management directors);
|
|
•
|
have the ability and be willing to spend the time required to function effectively as a director;
|
|
•
|
be compatible and able to work well with other directors and executives in a team effort with a view to a long-term relationship with the Company as a director; and
|
|
•
|
possess independent opinions and be willing to express them in a constructive manner.
|
|
|
Fees earned or paid in cash
|
Stock awards
|
Total
|
|
Name
|
($)
|
($)
(4)
|
($)
|
|
Michael Embler
(1)
|
$70,000
|
$79,991
|
$149,991
|
|
James G. Jones
(1)
|
$70,000
|
$79,991
|
$149,991
|
|
Michael Montgomery
(1)
|
$70,000
|
$79,991
|
$149,991
|
|
Regina L. Muehlhauser
(2)
|
$52,500
|
$159,982
|
$212,482
|
|
James H. Ozanne
(3)
|
$70,000
|
$79,991
|
$149,991
|
|
Steven L. Scheid
(3)
|
$70,000
|
$79,991
|
$149,991
|
|
(2)
|
Ms. Muehlhauser joined the Board on March 23, 2017.
|
|
(3)
|
James H. Ozanne and Steven L. Scheid have been members of the Board since the Company's capitalization on April 24, 2012.
|
|
(4)
|
The RSUs granted to each non-employee director in 2017 vest on the first anniversary of the date of grant, subject to continued service on the Board. Ms. Muehlhauser received an additional RSU grant in 2017 which vests in equal installments on each of the second and third anniversaries of the grant date, subject to her continued service on the Board. Amounts in this column represent the grant date fair value of the RSUs granted to our non-employee directors in fiscal year 2017, calculated in accordance with ASC Topic 718. As of December 31, 2017, each of Messrs. Ozanne and Scheid held stock options with respect to 75,625 shares of our common stock, and each of Messrs. Embler, Jones and Montgomery held stock options with respect to 37,813 shares of our common stock. As of December 31, 2017, each of Messrs. Ozanne, Scheid, Embler, Jones and Montgomery held 7,239 unvested RSUs and Ms. Muehlhauser held 14,478 unvested RSUs.
|
|
•
|
acting as the primary contact between the Company and the independent directors, undertaking to meet or confer periodically with members of the Company's executive team regarding matters related to the business of the Company;
|
|
•
|
assisting the Chairman of the Board, as necessary with conducting Board meetings;
|
|
•
|
assisting with preparation of agenda items for meetings of the Board and its committees; and
|
|
•
|
such other duties as the Board may from time to time assign to the Lead Director.
|
|
•
|
the integrity of the financial statements of the Company;
|
|
•
|
the independent auditor's qualifications and independence;
|
|
•
|
the performance of the Company's internal audit function and independent auditors;
|
|
•
|
the Company's system of disclosure controls and system of internal controls over financial reporting; and
|
|
•
|
the Company's compliance with legal and regulatory requirements.
|
|
•
|
overseeing our executive compensation program, including approving corporate goals relating to compensation for our CEO and other senior executives and determining the annual compensation of our CEO and other senior executives;
|
|
•
|
reviewing and approving the compensation policy recommended by management with respect to other employees;
|
|
•
|
determining, subject to ratification by our independent directors, the compensation of our independent directors;
|
|
•
|
evaluating the relationship between our risk management practices and our compensation policies and practices applicable to all employees, including our CEO, to consider whether they encourage risk-taking that would be reasonably likely to have a material adverse effect on the Company;
|
|
•
|
reviewing and approving incentive and equity-based compensation plans and grants; and
|
|
•
|
preparing the Compensation Committee Report and reviewing any Compensation Discussion and Analysis included in our proxy statements, to the extent such disclosure is required by SEC rules. Notwithstanding that these rules are not yet applicable to us because we currently qualify as an EGC under the Jumpstart Our Business Startups Act, we have opted to include a Compensation Discussion and Analysis in this Proxy Statement below to enhance the disclosures and provide relevant information to investors about our compensation program and philosophy. See "
Compensation of Named Executive Officers - Compensation Discussion and Analysis
" below.
|
|
•
|
identifying individuals qualified to become Board members and recommending to the Board nominees for election for the next annual meeting of stockholders;
|
|
•
|
reviewing the qualifications and independence of the members of the Board and its committees on a regular periodic basis;
|
|
•
|
recommending to the Board corporate governance guidelines and reviewing such guidelines, as well as the Governance and Nominating Committee charter, to confirm that they remain consistent with sound corporate governance practices and with any legal requirements;
|
|
•
|
leading the Board in its annual review of the Board's and its committees' performance; and
|
|
•
|
recommending committee assignments for members of the Board.
|
|
•
|
monitoring the performance of the Company's insured books of business and the principal factors affecting performance;
|
|
•
|
discussing, reviewing and monitoring the Company's mortgage insurance products, including premium rates, underwriting guidelines and returns;
|
|
•
|
reviewing and approving the Company's investment policy and reviewing the performance of the investment portfolio;
|
|
•
|
reviewing the mortgage insurance operating environment, including the state of local and regional housing markets, competitive forces affecting the Company and the Company's relationships with residential mortgage lenders and investors;
|
|
•
|
assisting the Board in its oversight of the Company's enterprise risk management approach, including the significant risk management policies, procedures and processes; and
|
|
•
|
reviewing and approving the Company's directors and officers liability coverage for adequacy and scope.
|
|
•
|
The Audit Committee oversees and reviews risks associated with financial accounting and reporting, including our system of internal controls, as well as fraud risk, information technology and cybersecurity risk, and major legislative and regulatory developments which could result in material financial risk exposures. In performing this function, the Audit Committee considers information from our independent registered public accounting firm and internal auditors and discusses relevant issues with management and the independent registered public accounting firm. The Audit Committee also reviews any proposed related person transactions to ensure that we do not engage in transactions that would create a conflict of interest that could result in harm to us.
|
|
•
|
The Compensation Committee evaluates the risks and rewards associated with our compensation philosophy and programs.
|
|
•
|
The Governance and Nominating Committee oversees our implementation of sound corporate governance principles and practices. In performing this function, the Governance and Nominating Committee periodically reviews and recommends changes to the Company's Corporate Governance Guidelines and recommends any additional actions related to governance matters that it may deem necessary or advisable from time to time.
|
|
•
|
The Risk Committee assists the Board in its oversight and review of information regarding our enterprise risk management approach and oversees risks related to our mortgage insurance business and investment portfolio.
|
|
•
|
whether the transaction is on terms that are fair and reasonable to the Company and substantially the same as would apply if the other party was not a related party;
|
|
•
|
the size of the transaction and the amount payable to the related party;
|
|
•
|
the nature of the interest of the related party in the transaction;
|
|
•
|
whether the transaction is in the business interests of the Company and in the interests of the Company's stockholders;
|
|
•
|
whether the transaction may involve a conflict of interest or otherwise interfere with the objectivity and independence of the related party; and
|
|
•
|
any other facts and circumstances that the members of the Committee or Chair, as applicable, deem relevant.
|
|
•
|
Our book of insurance-in-force (IIF), the principal source of our future revenue, grew by 44% in 2017, principally as a result of strong new insurance written (NIW) in 2017 of $21.6 billion, consisting of a higher percentage of monthly premium policies than in prior periods. For the year ended December 31, 2017, 81% of our NIW related to monthly premium policies, as compared to 67% at December 31, 2016 and 48% at December 31, 2015. As of December 31, 2017, monthly premium policies accounted for 69% of our primary IIF, as compared to 60% at December 31, 2016 and 47% at December 31, 2015.
|
|
•
|
We continued to manage our expenses, driving our expense ratio down to 64.5% in 2017 compared to 84.4% in 2016.
|
|
•
|
With an adjusted, annualized return on equity (ROE) of 11% for the fourth quarter ended December 31, 2017, we delivered on our goal of exiting 2017 with an adjusted ROE of approximately 10%.
*
|
|
•
|
Continued strong revenues driving our sustained profitability to produce adjusted net income of $38.3 million for the year ended December 31, 2017. Our net income in 2017 was adjusted to reflect a one-time non-cash expense of $13.6 million primarily related to the re-measurement of the Company's net deferred tax asset as a result of the 2017 Tax Cuts and Jobs Act (TCJA), and a pre-tax non-cash expense of $4.1 million related to the change in fair value of the Company's warrant liability as a result of the increase of its stock price.
*
|
|
•
|
Expanded our third-party reinsurance program in 2017 to support our continued business growth by securing a new quota-share reinsurance agreement that covers eligible policies through December 31, 2019 and executing on an excess-of-loss capital markets reinsurance transaction that provided for up to $211.3 million of aggregate excess-of-loss reinsurance coverage at inception for new defaults on an existing portfolio of our policies written from 2013 through December 31, 2016.
|
|
•
|
Improved debt service terms under our existing credit agreement by reducing the interest rate, extending the maturity date from November 10, 2018 to November 10, 2019 and removing a liquidity covenant.
|
|
•
|
Assists our Board in fulfilling its responsibilities related to the compensation of our CEO and other NEOs;
|
|
•
|
Oversees the administration of our compensation plans, in particular our incentive compensation and equity-based plans;
|
|
•
|
Evaluates performance in light of our annual goals and objectives; and
|
|
•
|
Reviews and makes recommendations to our Board concerning director compensation.
|
|
•
|
In consultation with the Committee's Compensation Consultant, Semler Brossy, reviewing and amending the peer group used by the Company to evaluate compensation to better align the peer group with, among other factors, the Company's size, revenues, geographic scope, and industry. See "-
Our Process for Executive Compensation - Benchmarking
" below for further discussion of our peer group;
|
|
•
|
Setting performance goals for the Company's 2017 bonus plan, including incentives to manage costs, write high-quality business to achieve sustainable revenues, achieve goals for adjusted net operating income and exit 2017 with an ROE of 10%;
|
|
•
|
Setting target and maximum amounts for cash incentives under the 2017 bonus plan for our executive officers, subject to the achievement of specified, pre-approved performance goals;
|
|
•
|
Developing a long-term performance-based equity grant for our CEO, with vesting contingent on the Company meeting certain ROE targets for fiscal years 2018 and 2019. See "-
CEO Compensation
" below for a description of our CEO's performance-based RSU award; and
|
|
•
|
Developing an equity grant strategy for 2017 that included a mix of options and RSUs for our NEOs.
|
|
•
|
No granting of options with an exercise price less than the fair market value of our common stock on the date of grant;
|
|
•
|
No re-pricing of options without stockholder approval;
|
|
•
|
No payment of dividends before vesting;
|
|
•
|
No recycling of shares tendered to or withheld by the Company to satisfy the exercise price of options or stock appreciation rights;
|
|
•
|
No granting of more than 5% of awards under the plan with a vesting period of less than one-year (subject to limited exceptions); and
|
|
•
|
Limits on non-employee director awards.
|
|
|
|
|
Max
|
Target
|
Threshold
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2018 ROE Goals
*
|
|
15% +
|
14%
|
12%
|
< 12%
|
|
|
|
|
|
|
|
|
|
|
|
|
2018 RSU Vest
|
|
125%
|
100%
|
50%
|
0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
2018 ROE, expressed as a percentage, means the Company's GAAP net income for the fourth quarter of 2018 multiplied by 4, which product is divided by the average shareholders' equity for the fourth quarter of 2018. With respect to its determination of whether the 2018 or 2019 ROE Goals have been met, the Committee reserves discretion as provided under the award agreement and 2014 Plan.
|
|
NMI 2018 Peer Group
|
Mortgage Insurer Direct Competitor
|
Broader Exposure to Insurance and Real Estate
|
Chose NMI as Peer
(1)
|
Business
|
|
Assured Guaranty
|
|
X
|
|
Financial Guaranty Insurer
|
|
PennyMac Financial Services
|
|
X
|
|
Mortgage Service & Lending
|
|
Radian Group Inc.
|
X
|
X
|
X
|
Mortgage Insurer
|
|
MGIC Investment Corporation
|
X
|
X
|
X
|
Mortgage Insurer
|
|
Flagstar Bancorp
|
|
X
|
|
Mortgage Originations & Servicing; Banking
|
|
James River Group
|
|
X
|
|
Specialty Insurance & Reinsurance
|
|
PHH Corp
|
|
X
|
|
Mortgage Servicing & Lending
|
|
Essent Group Ltd.
|
X
|
X
|
X
|
Mortgage Insurer
|
|
Baldwin & Lyons
|
|
X
|
X
|
Property & Casualty Insurance; Reinsurance
|
|
Redwood Trust
|
|
X
|
X
|
Mortgage Banking and Investments
|
|
Atlas Financial Holdings
|
|
X
|
|
Property & Casualty Insurance
|
|
Kinsale Capital Group
|
|
X
|
|
Property & Casualty Insurance
|
|
Investors Title
|
|
X
|
|
Property & Casualty Insurance
|
|
Kingstone Cos.
|
|
X
|
|
Property & Casualty Insurance
|
|
National Security Group
|
|
X
|
|
Property & Casualty Insurance; Life Insurance
|
|
Unico American
|
|
X
|
|
Property & Casualty Insurance
|
|
(1)
|
Based on 2016 proxy statements.
|
|
Compensation Element
|
|
Description
|
|
Alignment with Compensation Philosophy
|
|
Annual Compensation:
|
|
|
|
|
|
Annual Base Salary
|
|
● Fixed component of annual cash compensation that reflects expertise and scope of responsibilities, influenced by market pay levels and trends and individual performance
|
|
● Attract and retain key talent with market competitive salaries
● Provide financial certainty and stability
● Recognition of individual performance
|
|
Annual Bonus Plan
|
|
● Cash incentive plan based on performance and relative to Company and individual objectives
● Requirement that executive be employed at the time the bonus is paid has a retentive effect
|
|
● Balance between short- and long-term corporate goals that align with company's pay-for-performance philosophy and stockholders' interests with payouts that are determined based on meeting certain company financial metrics
● Short-term growth important in mortgage insurance business, because each book year of business supports the long-term growth of the Company
|
|
Long-Term Compensation:
|
|
|
|
|
|
Long-Term Incentive Program
|
|
● Equity-based, with focus on mix of RSUs and options as determined annually
|
|
● Aligns management and stockholder interests on increasing share value
|
|
Other Executive Benefits:
|
|
|
|
|
|
Retirement Program
|
|
● Participation in a 401(k) plan, including a matching contribution by the Company of 100% of the executive's contribution up to 4% of the executive's eligible compensation
|
|
● Attract and retain key talent
● Provide income security for retirement
|
|
Executive Cash Allowance Program
|
|
● Fixed cash amount to be used at the discretion of the executive, in lieu of individualized perquisite programs
|
|
● Attract and retain key talent
● Provide total compensation package that is competitive in our market and geographic location
|
|
NEO
|
2017 Annual
Base Salary |
|
Bradley M. Shuster
|
$787,500
|
|
Adam S. Pollitzer
|
$437,500
|
|
Claudia J. Merkle
|
$464,000
|
|
NEO
|
Target Award % of Salary
|
2017 Target Award
|
|
Bradley M. Shuster
|
100%
|
$787,500
|
|
Adam S. Pollitzer
|
100%
|
$437,500
|
|
Claudia J. Merkle
|
100%
|
$464,000
|
|
Performance Goals
|
2016 Weighting
|
2017 Weighting
|
|
4Q'17 Return on Equity
|
—
|
30%
|
|
Adjusted Net Operating Income
|
45%
|
30%
|
|
New Insurance Written
|
45%
|
25%
|
|
Adjusted Expense Ratio
|
10%
|
15%
|
|
NEO
|
Number of Restricted Stock Units
|
Number of
Securities Underlying Options |
Grant Date
Fair Value of Stock and Options |
|
Bradley M. Shuster
|
—
|
330,788
|
$1,300,223
|
|
Adam S. Pollitzer
|
23,148
|
68,893
|
$499,997
|
|
Claudia J. Merkle
|
26,126
|
73,791
|
$580,048
|
|
NEO
|
Number of Restricted Stock Units
|
Grant Date
Fair Value of Stock Awards |
|
Bradley M. Shuster
|
128,378
|
$1,424,996
|
|
Adam S. Pollitzer
|
185,185
|
$1,999,998
|
|
▪
|
CEO 5.0 x base salary
|
|
▪
|
President 3.0 x base salary
|
|
▪
|
EVPs 3.0 x base salary
|
|
NEO
|
Severance
Multiple
|
COBRA
Period
|
|
Bradley M. Shuster
|
2x
|
24 months
|
|
Adam S. Pollitzer
|
1.5x
|
18 months
|
|
Claudia J. Merkle
|
1.5x
|
18 months
|
|
Name and Principal Position
|
Year
|
Salary
|
Bonus
(1)
|
Stock Awards
(2)
|
Option Awards
(3)
|
Non-Equity Incentive Plan Compensation
(4)
|
Nonqualified Deferred Compensation Earnings
|
All Other Compensation
(5)
|
Total
|
|
Bradley M. Shuster, Chief Executive Officer
|
2017
|
$781,250
|
$—
|
$1,424,996
|
$1,300,223
|
$1,063,125
|
$—
|
$58,101
|
$4,627,695
|
|
2016
|
$668,750
|
$1,398,153
|
$1,019,956
|
$—
|
$—
|
$—
|
$61,163
|
$3,148,022
|
|
|
2015
|
$600,000
|
$1,110,000
|
$493,700
|
$807,669
|
$—
|
$—
|
$56,672
|
$3,068,041
|
|
|
Adam S. Pollitzer, Chief Financial Officer
|
2017
|
$290,265
|
$—
|
$2,249,996
|
$249,999
|
$560,000
|
$—
|
$361,013
|
$3,711,273
|
|
Claudia J. Merkle, Chief Operating Officer
|
2017
|
$461,667
|
$—
|
$289,999
|
$290,049
|
$593,920
|
$—
|
$44,304
|
$1,679,939
|
|
2016
|
$407,917
|
$702,193
|
$449,989
|
$—
|
$—
|
$—
|
$41,200
|
$1,601,299
|
|
|
2015
|
$358,333
|
$503,600
|
$76,500
|
$263,916
|
$—
|
$—
|
$40,600
|
$1,242,949
|
|
|
(1)
|
The bonus amounts for each fiscal year presented include each NEO's annual incentive bonus that was earned in such year but awarded at the discretion of the Committee and paid in the subsequent fiscal year.
|
|
(2)
|
Represents the grant date fair value of the RSUs granted to our NEOs in the respective fiscal year, calculated in accordance with FASB ASC Topic 718, Compensation-Stock Compensation (ASC Topic 718). See Note 10, "Share-Based Compensation" of our consolidated financial statements filed with the SEC on Form 10-K for the fiscal year ended December 31, 2017 for an explanation of the assumptions made in valuing these awards. For Mr. Shuster, the amount in this column represents the grant date fair value of Tranche 1 of his performance-based RSUs granted to him in February 2017, assuming achievement at the target level of performance. The value of Tranche 1 on the grant date would have been $1,781,239, assuming achievement at the max level of performance.
|
|
(3)
|
Represents the grant date fair value of stock options granted to our NEOs in the respective fiscal year, calculated in accordance with ASC Topic 718. See Note 10, "Share-Based Compensation" of our consolidated financial statements filed with the SEC on Form 10-K for the fiscal year ended December 31, 2017 for an explanation of the assumptions made in valuing these awards.
|
|
(4)
|
The amounts shown in this column represent each NEO's 2017 annual incentive bonus that was earned in 2017 but awarded and paid in 2018. The 2017 bonus plan was established and paid under the 2014 Plan. See "
Compensation Discussion and Analysis - Elements of Executive Compensation Program - Compensation Program Details - Annual Bonus Plan,"
above for a discussion of our NEO's fiscal year 2017 bonuses.
|
|
(5)
|
The Company includes in the annual compensation of each NEO a standardized, fixed cash amount to be used at the discretion of the executive officer, in lieu of individualized perquisite programs. In each of the years presented, the additional compensation under this program was $38,400 for Mr. Shuster and $30,000 for Ms. Merkle, and in 2017, Mr. Pollitzer received $20,000, prorated from an annualized amount of $30,000. In 2017, the additional compensation for Mr. Pollitzer also included $330,526 of relocation benefits paid pursuant to his offer letter. See "-
Employment Arrangements with our NEOs - Employment Arrangement with Adam Pollitzer
," below for a description of Mr. Pollitzer's relocation benefits. The amounts in this column also include Company matching contributions under the Company's 401(k) plan, as discussed above in "
Compensation Discussion and Analysis - Elements of Executive Compensation Program - Compensation Program Details - Retirement Plan
."
|
|
•
|
Mr. Shuster's annual base salary and target bonus opportunity are determined annually by the Committee. In 2017, Mr. Shuster's annual base salary was $787,500, with a target bonus opportunity of 100% of his annual base salary, payment of which is discretionary and conditioned on the attainment of certain corporate performance conditions as determined by the Committee in its discretion.
|
|
•
|
Mr. Shuster will receive employee benefits on a basis no less favorable than those provided to our other senior executives, including participation in the Company's 401(k) plan and executive cash allowance program, as discussed above in "
Compensation Discussion and Analysis - Elements of Executive Compensation Program.
"
|
|
•
|
Mr. Shuster's employment agreement provides for certain severance benefits, including if the Company terminates his employment without cause or for good reason. See below under
"- Potential Payments Upon Termination of Employment or Change in Control as of December 31, 2017
" for a description of the severance benefits that Mr. Shuster would have been eligible to receive as of December 31, 2017. In 2017, Mr. Shuster's change-in-control severance benefits under his employment agreement were replaced by the severance benefits under the Company's CIC Severance Plan and will be paid in lieu of, and not in addition to, the severance benefits described in Mr. Shuster's employment agreement, upon a severance-qualifying termination of employment under the CIC Severance Plan. See "
Compensation Discussion and Analysis - Other Aspects of our Executive Compensation Program - Change In Control Severance Plan,
" above.
|
|
|
Grant Date
|
Estimated Future Payouts
under Non-Equity Incentive
Plan Awards
(1)
|
Estimated Future Payouts
under Equity Incentive
Plan Awards
(2)
|
All Other Stock Awards: Number of Shares of Stock or Units (#)
|
All Other Option Awards: Number of Securities Underlying Options (#)
(3)
|
Exercise or Base price of Option Awards ($/Sh)
|
Grant Date Fair Value of Stock and Option Awards ($)
(4)
|
||||
|
Name
|
Threshold
($) |
Target
($) |
Maximum
($) |
Threshold
(#) |
Target
(#) |
Maximum
(#) |
|||||
|
Bradley M. Shuster
|
—
|
$—
|
$787,500
|
$1,575,000
|
—
|
—
|
—
|
—
|
—
|
$—
|
$—
|
|
2/9/2017
|
$—
|
$—
|
$—
|
64,189
|
128,378
|
160,472
|
—
|
—
|
$—
|
$1,424,996
|
|
|
2/9/2017
|
$—
|
$—
|
$—
|
—
|
—
|
—
|
—
|
330,788
|
$11.10
|
$1,300,223
|
|
|
Adam S. Pollitzer
|
—
|
$—
|
$437,500
|
$875,000
|
—
|
—
|
—
|
—
|
—
|
$—
|
$—
|
|
5/10/2017
|
$—
|
$—
|
$—
|
—
|
—
|
—
|
23,148
(5)
|
—
|
$—
|
$249,998
|
|
|
5/10/2017
|
$—
|
$—
|
$—
|
—
|
—
|
—
|
185,185
(6)
|
—
|
$—
|
$1,999,998
|
|
|
5/10/2017
|
$—
|
$—
|
$—
|
—
|
—
|
—
|
—
|
68,893
|
$10.80
|
$249,999
|
|
|
Claudia J. Merkle
|
—
|
$—
|
$464,000
|
$928,000
|
—
|
—
|
—
|
—
|
—
|
$—
|
$—
|
|
2/9/2017
|
$—
|
$—
|
$—
|
—
|
—
|
—
|
26,126
(5)
|
—
|
$—
|
$289,999
|
|
|
2/9/2017
|
$—
|
$—
|
$—
|
—
|
—
|
—
|
—
|
73,791
|
$11.10
|
$290,049
|
|
|
(1)
|
The actual amounts earned in 2017 but awarded and paid in 2018 are shown in the Non-Equity Incentive Plan Compensation column of the 2017 Summary Compensation Table, above. See "
Compensation Discussion and Analysis
-
Elements of Executive Compensation Program - Compensation Program Details - Annual Bonus Plan"
for more information.
|
|
(2)
|
Mr. Shuster’s performance-based RSUs are eligible to vest on December 31, 2018 for Tranche 1 and December 31, 2019 for Tranche 2, in each case, subject to Mr. Shuster's continued employment with the Company through the applicable vesting date. The actual number of shares subject to Tranche 1 and Tranche 2 that are potentially earned will be based on the satisfaction of the 2018 ROE Goals and the 2019 ROE Goals, respectively. Tranche 2 is not reported in the table above because the grant date for Tranche 2 is February 7, 2018. See "
Compensation Discussion and Analysis
-
Executive Summary - CEO Compensation
," above for a description of Mr. Shuster's performance-based RSU grant.
|
|
(3)
|
These stock option grants vest in 1/3 increments (rounded down to the nearest whole share) on the first, second, and third anniversaries of the grant date.
|
|
(4)
|
The amounts included in this column reflect the grant date fair value of stock option and RSU awards to our NEOs in 2017. The grant date fair value was determined in accordance with ASC Topic 718. For Mr. Shuster, the amount in this column represents the grant date fair value of Tranche 1 of his performance-based RSUs granted to him in February 2017, assuming achievement at the target level of performance. The value of Tranche 1 on the grant date would have been $1,781,239, assuming achievement at the max level of performance.
|
|
(5)
|
These RSU grants vest in 1/3 increments (rounded down to the nearest whole share) on the first, second and third anniversaries of the grant date.
|
|
(6)
|
The Company made this inducement-based equity award of RSUs to Mr. Pollitzer in connection with entering into Mr. Pollitzer's offer letter. This RSU grant vests in 1/5 increments (rounded down to the nearest whole share) on the first through fifth anniversaries of the grant date.
|
|
|
|
Option Awards
|
Stock Awards
|
|||||||
|
Name
|
Grant Year
|
Number of Securities Underlying Unexercised Options Exercisable (#)
|
Number of Securities Underlying Unexercised Options Unexercisable (#)
|
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)
|
Option Exercise Price ($)
|
Option Expiration Date
|
Number of Shares or Units of Stock That Have Not Vested (#)
|
Market Value of Shares or Units of Stock That Have Not
Vested ($)
(10)
|
Equity
Incentive
Plan Awards:
Number of
Unearned
Shares, Units or
Other Rights
That Have Not
Vested (#)
|
Equity
Incentive
Plan Awards:
Market or
Payout Value
of Unearned
Shares, Units or
Other Rights
That Have Not
Vested ($)
(10)
|
|
Bradley M. Shuster
|
2012
|
907,500
|
—
|
—
|
$10.00
|
4/24/2022
|
—
|
$—
|
—
|
$—
|
|
2013
|
133,333
|
—
|
—
|
$11.75
|
2/14/2023
|
—
|
$—
|
—
|
$—
|
|
|
2014
|
151,700
|
—
|
—
|
$12.32
|
2/12/2024
|
—
|
$—
|
—
|
$—
|
|
|
2015
|
175,866
|
87,934
(1)
|
—
|
$8.50
|
2/12/2025
|
21,268
(2)
|
$361,556
|
—
|
$—
|
|
|
2016
|
—
|
—
|
—
|
$—
|
—
|
142,254
(3)
|
$2,418,318
|
—
|
$—
|
|
|
2017
|
—
|
330,788
(4)
|
—
|
$11.10
|
2/9/2027
|
—
|
$—
|
160,472
(5)
|
$2,728,024
|
|
|
Adam S. Pollitzer
|
2017
|
—
|
68,893
(6)
|
—
|
$10.80
|
5/10/2027
|
208,333
(7)
|
$3,541,661
|
—
|
$—
|
|
Claudia J. Merkle
|
2012
|
12,000
|
—
|
—
|
$10.00
|
5/30/2022
|
—
|
$—
|
—
|
$—
|
|
2012
|
12,000
|
—
|
—
|
$10.00
|
11/7/2022
|
—
|
$—
|
—
|
$—
|
|
|
2013
|
30,247
|
—
|
—
|
$11.75
|
2/14/2023
|
—
|
$—
|
—
|
$—
|
|
|
2014
|
76,000
|
—
|
—
|
$12.32
|
2/12/2024
|
—
|
$—
|
—
|
$—
|
|
|
2015
|
57,466
|
28,734
(1)
|
—
|
$8.50
|
2/12/2025
|
3,000
(8)
|
$51,000
|
—
|
$—
|
|
|
2016
|
—
|
—
|
—
|
$—
|
—
|
62,760
(3)
|
$1,066,920
|
—
|
$—
|
|
|
2017
|
—
|
73,791
(4)
|
—
|
$11.10
|
2/9/2027
|
26,126
(9)
|
$444,142
|
—
|
$—
|
|
|
(1)
|
Remaining stock options scheduled to vest 100% on 2/12/2018.
|
|
(2)
|
Amount includes 11,268 unvested RSUs from an award granted to Mr. Shuster on 2/12/2015, which are scheduled to vest 100% on 2/12/2018, and 10,000 unvested RSUs from an award granted to Mr. Shuster on 12/23/2015, which are scheduled to vest 100% on 12/23/2018.
|
|
(3)
|
Remaining
RSUs scheduled to vest 50% on 2/10/2018 and 50% on 2/10/2019.
|
|
(4)
|
Stock options scheduled to vest in thirds (rounded down to the nearest whole share) on 2/9/2018, 2/9/2019 and 2/9/2020.
|
|
(5)
|
Mr. Shuster’s performance-based RSUs are eligible to vest on December 31, 2018 for Tranche 1 and December 31, 2019 for Tranche 2, in each case, the number of shares earned subject to satisfaction of certain ROE goals, as described above under “-
Executive Summary - CEO Compensation
.” Based on the grant dates applicable to Tranche 1 and Tranche 2, Tranche 1 but not Tranche 2 is reported in the table above. With respect to Tranche 1, the number reported in the table is based on max performance.
|
|
(6)
|
Stock options scheduled to vest in thirds (rounded down to the nearest whole share) on 5/10/2018, 5/10/2019 and 5/10/2020.
|
|
(7)
|
Amount includes 23,148 unvested RSUs from an award granted to Mr. Pollitzer on 5/10/2017, which are scheduled to vest in thirds
(rounded down to the nearest whole share) on 5/10/2018, 5/10/2019 and 5/10/2020, and 185,185
unvested RSUs from an award granted to Mr. Pollitzer on 5/10/2017, which are scheduled to vest in fifths
(rounded down to the nearest whole share) on 5/10/2018, 5/10/2019, 5/10/2020, 5/10/2021 and 5/10/2022.
|
|
(8)
|
Remaining RSUs scheduled to vest 100% on 2/12/2018.
|
|
(9)
|
RSUs scheduled to vest in thirds
(rounded down to the nearest whole share)
on 2/9/2018, 2/9/2019 and 2/9/2020.
|
|
(10)
|
The payout value is based on the $17.00 closing price of our common stock on NASDAQ on December 29, 2017 multiplied by the number of unvested RSUs as of December 31, 2017.
|
|
Name
|
Scenario
|
Cash Severance ($)
|
Stock Option Vesting ($)
|
Restricted Stock Unit Vesting ($)
|
Benefits ($)
|
Total ($)
|
|
Bradley M. Shuster
|
Voluntary Resignation (no Good Reason)
|
- (1)
|
-
|
-
|
- (2)
|
-
|
|
Termination without Cause or for Good Reason
|
$1,575,000 (3)
|
$2,699,088 (4)
|
$2,779,874 (5)
|
- (2)
|
$7,053,962
|
|
|
Involuntary Termination for Cause
|
- (1)
|
-
|
-
|
- (2)
|
-
|
|
|
Termination Following Change in Control
|
$3,937,500 (6)
|
$2,699,088 (7)
|
$7,144,726 (8)
|
$34,857 (9)
|
$13,816,171
|
|
|
No Termination Following Change in Control
|
-
|
$2,699,088 (7)
|
$7,144,726 (8)
|
-
|
$9,843,814
|
|
|
Adam S. Pollitzer
|
Voluntary Resignation (no Good Reason)
|
-
|
-
|
-
|
-
|
-
|
|
Termination without Cause
|
$109,375 (10)
|
$427,137 (4)
|
- (11)
|
$7,518 (10)
|
$544,030
|
|
|
Involuntary Termination for Cause
|
-
|
-
|
-
|
-
|
-
|
|
|
Termination Following Change in Control
|
$1,750,000 (12)
|
$427,137 (7)
|
$3,541,661 (8)
|
$45,107 (9)
|
$5,763,905
|
|
|
No Termination Following Change in Control
|
-
|
$427,137 (7)
|
$3,541,661 (8)
|
-
|
$3,968,798
|
|
|
Claudia J. Merkle
|
Voluntary Resignation (no Good Reason)
|
-
|
-
|
-
|
-
|
-
|
|
Termination without Cause
|
$464,000 (10)
|
$344,684 (13)
|
-
|
$20,819 (10)
|
$829,503
|
|
|
Involuntary Termination for Cause
|
-
|
-
|
-
|
-
|
-
|
|
|
Termination Following Change in Control
|
$1,856,000 (12)
|
$679,606 (7)
|
$1,562,062 (8)
|
$31,228 (9)
|
$4,128,896
|
|
|
No Termination Following Change in Control
|
-
|
$679,606 (7)
|
$1,562,062 (8)
|
-
|
$2,241,668
|
|
|
(1)
|
Under the terms of Mr. Shuster's employment agreement, he would be entitled to be paid any Accrued Compensation.
|
|
(2)
|
Under the terms of Mr. Shuster's employment agreement, he would be entitled to be paid any Accrued Benefits.
|
|
(3)
|
As provided in Mr. Shuster's employment agreement, amount is equal to the sum of (1) any Accrued Compensation and (2) the sum of one times his annual base salary at the time of termination and one times his target annual bonus for the year in which the termination occurs, which, for 2017, was 100% of his annual base salary.
|
|
(4)
|
Upon a termination of employment without "cause" or for "good reason," any outstanding stock options that were not then exercisable and vested would have become fully exercisable and vested at the date of such termination. As of December 31, 2017, all of our NEOs' outstanding, unvested stock options were "in the money," meaning that such options had an exercise price less than the Closing Price. See "
Outstanding Equity Awards at 2017 Fiscal Year End,
" above.
|
|
(5)
|
With a termination of employment without "cause" or for "good reason," unvested time-vested RSUs would have become fully vested at the date of termination and unvested performance RSUs would have remained outstanding and subject to vesting upon the achievement of the applicable ROE goals, as determined by the Committee in accordance with the terms of the award agreement.
|
|
(6)
|
As a participant in the CIC Severance Plan, Mr. Shuster would be entitled to a cash payment equal to the sum of (i) two times the sum of Mr. Shuster's annual base salary and target annual bonus, in each case as in effect immediately prior to the termination and (ii) Mr. Shuster's target annual bonus for the fiscal year in which the termination occurs, pro-rated through the date of termination as described in the CIC Severance Plan.
|
|
(7)
|
Upon a change in control, any outstanding stock options that were not then exercisable and vested would have become fully exercisable and vested as of the date of such change in control. As of December 31, 2017, all of our NEOs' outstanding, unvested stock options were in the money, with an exercise price less than the Closing Price. See "
Outstanding Equity Awards at 2017 Fiscal Year End,
" above.
|
|
(8)
|
Upon a change in control, unvested time-vested RSUs would have become fully vested and, for Mr. Shuster, 100% of the shares subject to Tranche 1 and Tranche 2 of his performance-based RSUs would have become fully vested.
|
|
(9)
|
As participants in the CIC Severance Plan, each NEO would be entitled to a lump sum cash payment equal to the cost of medical insurance premiums for the duration of the participant's COBRA period, which for Mr. Shuster is 24 months and for Mr. Pollitzer and Ms. Merkle is 18 months.
|
|
(10)
|
Amounts payable under the Severance Plan upon a Terminating Event, which for Mr. Pollitzer would have been three months' base salary and three months' of health coverage contributions and for Ms. Merkle would have been 12 months' base salary and 12 months' health coverage contributions. See "-
Termination of Employment without Cause or Resignation with Good Reason - Severance Plan Benefits
," above.
|
|
(11)
|
Under Mr. Pollitzer's RSU award agreements, if his employment is terminated by us without cause, subject to Mr. Pollitzer having served as an employee of the Company for at least one year, a prorated portion of his outstanding unvested RSUs that would have vested on the next vesting date would vest, based on the number of days that he was employed during the applicable vesting term. If Mr. Pollitzer had incurred a termination without
|
|
(12)
|
As participants in the CIC Severance Plan, Mr. Pollitzer and Ms. Merkle would be entitled to a cash payment equal to the sum of (i) one and one-half times the sum of the executive's annual base salary and target annual bonus, in each case as in effect immediately prior to the termination and (ii) the executive's target annual bonus for the fiscal year in which the termination occurs, pro-rated through the date of termination as described in the CIC Severance Plan.
|
|
(13)
|
With a termination of employment without "cause," a prorated portion of Ms. Merkle's outstanding, unvested stock options that would have vested at the next vesting date would have become fully exercisable and vested at the date of termination. See "
Outstanding Equity Awards at 2017 Fiscal Year End,
" above.
|
|
•
|
each person known to us to be the beneficial owner of more than five percent of our Class A common stock;
|
|
•
|
each NEO;
|
|
•
|
each of our directors; and
|
|
•
|
all of our current executive officers, identified above under the caption "
Executive Officers,
" and directors as a group.
|
|
|
Shares of Class A Common
Stock Beneficially Owned
|
|
|
|
Number
|
%
|
|
Named Executive Officers and Directors:
|
|
|
|
Bradley M. Shuster
(1)
|
2,236,569
|
3.3%
|
|
Claudia J. Merkle
(2)
|
277,807
|
*
|
|
Adam Pollitzer
(3)
|
67,717
|
*
|
|
James H. Ozanne
(4)
|
205,331
|
*
|
|
Steven L. Scheid
(5)
|
164,893
|
*
|
|
Michael Embler
(6)
|
119,084
|
*
|
|
James G. Jones
(7)
|
203,084
|
*
|
|
Michael Montgomery
(8)
|
51,197
|
*
|
|
Regina Muehlhauser
(9)
|
17,239
|
*
|
|
All executive officers and directors as a group (11 persons)
|
3,882,458
|
5.7%
|
|
*
|
Represents less than 1% beneficial ownership.
|
|
(1)
|
Represents 509,201 shares held directly, 160,773 shares held indirectly in the Shuster Family Trust, of which Mr. Shuster and his wife are co-trustees and beneficiaries, and 1,566,595 vested stock options.
|
|
(2)
|
Represents 36,763 shares held directly and 241,044 vested stock options.
|
|
(3)
|
Represents 44,753 RSUs expected to vest within 60 days of March 26, 2018 and 22,964 options expected to vest within 60 days of March 26, 2018.
|
|
(4)
|
Represents 77,467 shares held directly (including 10,000 shares held in the James H. Ozanne Revocable Trust of which Mr. Ozanne is the sole trustee and beneficiary), 10,000 shares held in the Susan A. Ozanne Family Trust of which Mr. Ozanne and his wife are co-trustees and beneficiaries, 35,000 shares held by Greenrange Partners LLC, a venture capital investment company for which Mr. Ozanne serves as principal, 75,625 vested stock options and 7,239 RSUs expected to vest within 60 days of March 26, 2018.
|
|
(5)
|
Represents 72,029 shares held directly, 10,000 shares held in the Scheid Family Trust of which Mr. Scheid and his wife are co-trustees and beneficiaries, 75,625 vested stock options and 7,239 RSUs expected to vest within 60 days of March 26, 2018.
|
|
(6)
|
Represents 74,032 shares held directly, 37,813 vested stock options and 7,239 RSUs expected to vest within 60 days of March 26, 2018.
|
|
(7)
|
Represents 79,032 shares held directly, 57,000 shares held in the James G. Jones and Maria F. Jones Revocable Trust, 20,000 shares held by the Jennie K. Jones Irrevocable Living Trust, of which Mr. Jones is the sole trustee, 2,000 shares held in the Jaime C. Jones Irrevocable Living Trust, of which Mr. Jones is the sole trustee, 37,813 vested stock options and 7,239 RSUs expected to vest within 60 days of March 26, 2018.
|
|
(8)
|
Represents 6,145 shares held directly and 37,813 vested stock options 7,239 RSUs expected to vest within 60 days of March 26, 2018.
|
|
(9)
|
Represents 10,000 shares held directly and 7,239 RSUs expected to vest within 60 days of March 26, 2018.
|
|
Greater than 5% Stockholders, as of March 26, 2018
|
Number
|
%
|
|
BlackRock, Inc. (1)
|
7,192,807
|
11.0%
|
|
Oaktree Capital Management LP (2)
|
5,681,992
|
8.7%
|
|
SMALLCAP World Fund Inc (3)
|
4,800,127
|
7.3%
|
|
Vanguard Group Inc (4)
|
3,992,653
|
6.1%
|
|
Wellington Management Group LLP (5)
|
3,789,861
|
5.8%
|
|
Capital Research Global Investors (6)
|
3,481,202
|
5.3%
|
|
(1)
|
Based on a Schedule 13G/A filed with the SEC on January 19, 2018. The number of shares reported includes: (a) 7,080,044 over which it has sole voting power and (b) 7, 192,807 over which it has sole dispositive power. Subsidiaries of BlackRock, Inc. reported to have acquired the securities being reported include BlackRock Advisors, LLC, BlackRock Investment Management (UK) Limited, BlackRock Asset Management Canada Limited, BlackRock (Netherlands) B.V., BlackRock Fund Advisors, BlackRock Asset Management Ireland Limited, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., BlackRock Asset Management Schweiz AG, and BlackRock Investment Management, LLC. The principal business address of BlackRock, Inc. is 55 East 52nd Street, New York, New York 10055.
|
|
(2)
|
Based on a Schedule 13G/A filed with the SEC on February 9, 2018. The number of shares reported includes: (a) 5,681,992 shares over which Oaktree Value Equity Holdings, L.P. (VE Holdings) has sole voting and dispositive power. Oaktree Value Equity Fund GP, L.P. (VEF GP) is the general partner of VE Holdings. Oaktree Value Equity Fund GP Ltd. (VEF Ltd.) is the general partner of VEF GP. Oaktree Value Equity Fund-SP GP, L.P. (VEF-SP GP) is the general partner of Oaktree Value Equity Fund-SP, L.P. (VEF-SP). Oaktree Capital Management, L.P. (Management) is the sole director of VEF Ltd and the general partner of VEF-SP GP. Oaktree Holdings, Inc. (Holdings) is the general partner of Management. Oaktree Fund GP I, L.P. (GP I) is the sole shareholder of VEF Ltd. Oaktree Capital I, L.P. (Capital I) is the general partner of GP I. OCM Holdings I, LLC (OCM Holdings I) is the general partner of Capital I. Oaktree Holdings, LLC (Holdings LLC) is the managing member of Holdings, I. Oaktree Capital Group, LLC (OCG) is the sole shareholder of Holdings and the managing member of Holdings LLC. Oaktree Capital Group Holdings, GP, LLC, (OOGH) is the manager of OCG. The principal business address for each of the above reporting persons is 333 S. Grand Avenue, 28th Floor, Los Angeles, CA 90071.
|
|
(3)
|
Based on a Schedule 13G filed with the SEC on February 14, 2018. SMALLCAP World Fund, Inc. reports that it is an investment company registered under the Investment Company Act of 1940, which is advised by Capital Research and Management Company (CRMC) and is the beneficial owner of the shares reported. CRMC manages equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital World Investors, and Capital International Investors. These divisions generally function separately from each other with respect to investment research activities and they make investment decisions and proxy voting decisions for the investment companies on a separate basis. The principal business address of the reporting person is 6455 Irvine Center Drive, Irvine, California 92618-4518.
|
|
(4)
|
Based on a Schedule 13G filed with the SEC on February 9, 2018. The number of shares reported includes (a) 68,257 shares over which The Vanguard Group has sole voting power; (b) 2,000 shares over which The Vanguard Group has shared voting power; (c) 3,925,977 shares over which The Vanguard Group has sole dispositive power; and (d) 66,676 shares over which The Vanguard Group has shared dispositive power. Vanguard Fiduciary Trust Company (VFTC) a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 64,676 shares as a result of serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd (VIA) a wholly-owned subsidiary of The Vanguard Group, Inc. is the beneficial owner of 5,581 shares as a result of serving as investment manager of Australian investment offerings. The reporting person's principal business address is 100 Vanguard Blvd, Malvern, Pennsylvania 19355.
|
|
(5)
|
Based on a Schedule 13G filed with the SEC on February 8, 2018. The number of shares reported includes (a) 3, 358,719 shares over which it has shared voting power and (b) 3,789,861 shares over which it has shared dispositive power. The securities as to which the Schedule 13G is filed are owned of record by clients of one or more investment advisers directly or indirectly owned by Wellington Management Group LLP, including Wellington Group Holdings LLP, Wellington Investment Advisors LLP, Wellington Management Global Holdings, Ltd., Wellington Management Company LLP, Wellington Management Canada LLC, Wellington Management Singapore Pte Ltd, Wellington Management Hong Kong Ltd, Wellington Management International Ltd, Wellington Management Japan Pte Ltd and Wellington Management Australia Pty Ltd. The securities as to which the Schedule 13G is filed by Wellington Management Group LLP as parent holding company of certain holding companies and Wellington Investment Advisors, are owned of record by clients of the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP controls directly, or indirectly through Wellington Management Global Holdings, Ltd., the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP is owned by Wellington Group Holdings LLP. Wellington Group Holdings LLP is owned by Wellington Management Group LLP. The reporting person's principal business address is c/o Wellington Management Company LLP, 280 Congress Street, Boston MA 02210.
|
|
(6)
|
Based on a Schedule 13G filed with the SEC on February 14, 2018. The number of shares reported includes 3,481,202 shares over which the reporting person has sole voting power and sole dispositive power. As to the 3,481,202 shares, the reporting person disclaims beneficial ownership pursuant to Rule 13d-4. Capital Research Global Investors is a division of Capital Research and Management Company. The reporting person's principal business address is 333 South Hope Street, Los Angeles, California 90071.
|
|
Plan Category
|
Number of securities to be issued upon exercise of outstanding options, warrants, and rights (2)
|
Weighted-average exercise price of outstanding options, warrants, and rights (3)
|
Number of securities remaining available for future issuance under equity compensation plans (4)
|
|
Equity compensation plans approved by security holders (1)
|
5,375,324
|
$10.41
|
3,508,677
|
|
Equity compensation plans not approved by security holders
|
—
|
—
|
—
|
|
Total
|
5,375,324
|
$10.41
|
3,508,677
|
|
(1)
|
NMI Holdings, Inc. 2012 Stock Incentive Plan (2012 Plan) and NMI Holdings, Inc. Amended and Restated 2014 Omnibus Incentive Plan (2014 Plan).
|
|
(2)
|
Includes 2,794,880 and 515,900 shares to be issued upon exercise of outstanding stock options under the 2012 and 2014 Plans, respectively, and 49,325 and 2,015,219 shares of unvested RSUs granted under the 2012 and 2014 Plans, respectively.
|
|
(3)
|
Weighted-average exercise price is based solely on outstanding options.
|
|
(4)
|
The amount shown includes 1,054,836 shares available for use with awards granted under the 2012 Plan and 2,453,841 shares available for use with awards granted under the 2014 Plan.
|
|
|
2017
|
|
2016
|
||||
|
Audit Fees
|
$
|
790,532
|
|
|
$
|
638,430
|
|
|
Audit-Related Fees
|
—
|
|
|
—
|
|
||
|
Tax Fees
|
—
|
|
|
—
|
|
||
|
All Other Fees
|
—
|
|
|
—
|
|
||
|
Total Fees
|
$
|
790,532
|
|
|
$
|
638,430
|
|
|
(1)
|
Change in fair value of warrant liability
. Outstanding warrants at the end of each reporting period are revalued, and any change in fair value is reported in the statements of operations in the period in which the change occurred. The change in the fair value of our warrant liability can vary significantly across periods and is influenced principally by equity market and general economic factors which may not impact or reflect our current period operating results. Trends in our operating performance can be more clearly identified without the fluctuations of the change in fair value of our warrant liability.
|
|
(2)
|
Infrequent or unusual non-operating items.
Our income tax expense for 2017 reflects a one-time non-cash charge due to a re-measurement of our net deferred tax assets in connection with the enactment of the TCJA in the fourth quarter of 2017.
|
|
Non-GAAP Financial Measure Reconciliation
|
|||||||
|
|
|
|
|
||||
|
|
Quarter Ended
|
|
Year Ended
|
||||
|
(In Thousands, except for per share data)
|
Q4 2017
|
|
2017
|
||||
|
As Reported
|
|
|
|
||||
|
Revenues
|
|
|
|
||||
|
Net premiums earned
|
$
|
50,079
|
|
|
$
|
165,740
|
|
|
Net Investment Income
|
4,388
|
|
|
16,273
|
|
||
|
Net realized investment gains
|
9
|
|
|
208
|
|
||
|
Other revenues
|
62
|
|
|
522
|
|
||
|
Total revenues
|
54,538
|
|
|
182,743
|
|
||
|
Expenses
|
|
|
|
||||
|
Insurance claims and claims expenses
|
2,374
|
|
|
5,339
|
|
||
|
Underwriting and operating expenses
|
28,297
|
|
|
106,979
|
|
||
|
Total expenses
|
30,671
|
|
|
112,318
|
|
||
|
Other Expense
|
|
|
|
||||
|
Loss from change in fair value of warrant liability
|
(3,426
|
)
|
|
(4,105
|
)
|
||
|
Interest expense
|
(3,382
|
)
|
|
(13,528
|
)
|
||
|
Total other expense
|
(6,808
|
)
|
|
(17,633
|
)
|
||
|
|
|
|
|
||||
|
Income before income taxes
|
17,059
|
|
|
52,792
|
|
||
|
Income tax expense
|
18,825
|
|
|
30,742
|
|
||
|
Net income
|
$
|
(1,766
|
)
|
|
$
|
22,050
|
|
|
Adjustments:
|
|
|
|
||||
|
Loss from change in fair value of warrant liability
|
3,426
|
|
|
4,105
|
|
||
|
Adjusted Income before income taxes
|
20,485
|
|
|
56,897
|
|
||
|
|
|
|
|
||||
|
After-tax warrant adjustment
|
2,227
|
|
|
2,668
|
|
||
|
Deferred tax asset adjustments
|
13,554
|
|
|
13,554
|
|
||
|
Adjusted Net income
|
$
|
14,015
|
|
|
$
|
38,272
|
|
|
|
|
|
|
||||
|
Average Shareholder's Equity
|
510,256
|
|
|
492,498
|
|
||
|
Return on equity – Reported
|
(1.4
|
)%
|
|
4.5
|
%
|
||
|
Return on equity – Adjusted
|
11.0
|
%
|
|
7.8
|
%
|
||
|
(1)
|
Net realized investment gains (losses)
. The recognition of net realized investment gains or losses can vary significantly across periods as the timing of individual securities sales is highly discretionary and is influenced by such factors as market opportunities and overall market cycles. Trends in the profitability of our fundamental operating activities can be more clearly identified without the fluctuations of these realized investment gains and losses.
|
|
(2)
|
Bonus accruals
. Adjusted net operating income is the metric we used to set the threshold for the establishment of a bonus pool; therefore, the metric was defined in a manner that would illustrate trends in profitability and operating performance without the impact of bonuses. Bonus accruals are estimates recorded throughout the fiscal year, which are ultimately dependent on approval from the Compensation Committee.
|
|
NMI HOLDINGS, INC. 2100 POWELL STREET, 12th FLOOR EMERYVILLE, CA 94608
|
|
VOTE BY INTERNET
Before The Meeting -
Go to www.proxyvote.com
|
|
|
Use the Internet to transmit your voting instructions and for electronic delivery of information until 11:59 P.M. Eastern Time on Wednesday, May 09, 2018. Have this proxy card and the information that is printed in the box marked by the arrow in hand when you access the website and follow the instructions to obtain your records and to create an electronic voting instruction form.
|
|
|
|
During the Meeting -
Go to
www.virtualshareholdermeeting.com/NMIH2018
|
|
|
|
You may attend the Annual Meeting via the Internet and vote during the Annual Meeting until voting is closed. Have the information that is printed in the box marked by the arrow available and follow the instructions.
|
|
|
|
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions until 11:59 P.M. Eastern Time on Wednesday, May 09, 2018. Have your proxy card in hand when you call and then follow the instructions.
|
|
|
|
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
|
|
E41876-P0054
|
KEEP THIS PORTION FOR YOUR RECORDS
|
|
|
DETACH AND RETURN THIS PORTION ONLY
|
|
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
|
|
|
NMI HOLDINGS, INC.
|
For
All
|
Withhold
All
|
For All
Except
|
To withhold authority to vote for any individual nominee(s), mark "For All Except" and write the number(s) of the nominee(s) on the line below.
|
||||||||||||||||
|
|
The Board of Directors recommends you vote FOR the Election of Directors and FOR Proposal 2:
|
ú
|
ú
|
ú
|
|
|
|
|
|
|
|
|
||||||||
|
|
1.
|
Election of Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
01)
|
Bradley M. Shuster
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
02)
|
Michael Embler
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
03)
|
James G. Jones
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
04)
|
Michael Montgomery
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
05)
|
Regina Muehlhauser
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
06)
|
James H. Ozanne
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
07)
|
Steven L. Scheid
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
For
|
Against
|
Abstain
|
||||||||||||||
|
|
2.
|
Ratify the appointment of BDO USA, LLP as NMI Holdings, Inc.'s independent registered public accounting firm for the year ending December 31, 2018.
|
|
|
ú
|
ú
|
ú
|
|||||||||||||
|
|
3.
|
Such other business as may properly come before the meeting or any adjournment thereof.
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For address changes and/or comments, please check this box and write them on the back where indicated.
|
|
ú
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE: Please sign as name appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, trustee or guardian, please give full title as such.
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||
|
|
Signature [PLEASE SIGN WITHIN BOX]
|
Date
|
|
Signature (Joint Owners)
|
Date
|
|||||||||||||||
|
1.
|
The election of seven directors to the board of directors to serve until the 2019 Annual Meeting;
|
|
2.
|
The ratification of the appointment of BDO USA, LLP as NMI's independent registered public accounting firm for the year ending December 31, 2018; and
|
|
3.
|
Any other matters that properly come before the Annual Meeting.
|
|
|
|
|
E41877-P00544
|
||
|
PROXY
|
||
|
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF NMI HOLDINGS, INC
.
|
||
|
The undersigned hereby appoints Bradley M. Shuster and William J. Leatherberry, and each of them, with power to act without the other and with power of substitution, as proxies and attorneys-in-fact and hereby authorizes them to represent and vote, as provided on the other side, all the shares of Class A Common Stock of NMI Holdings, Inc. which the undersigned is entitled to vote and, in their discretion, to vote upon such other business as may properly come before the Annual Meeting of Stockholders of NMI Holdings, Inc. to be held on May 10, 2018 or any adjournment thereof, with all powers which the undersigned would possess if present at the Annual Meeting.
|
||
|
THIS PROXY CARD, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED. IF NO DIRECTION IS MADE BUT THE CARD IS SIGNED, THIS PROXY CARD WILL BE VOTED (1)
FOR
THE ELECTION OF ALL NOMINEES UNDER PROPOSAL 1; AND (2)
FOR
PROPOSAL 2; AND, IN THE DISCRETION OF THE PROXIES, WITH RESPECT TO SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING.
|
||
|
Address Changes/Comments:
|
|
|
|
(If you noted any Address Changes/Comments above, please mark corresponding box on the reverse side)
|
||
|
(Continued and to be marked, dated and signed, on the other side)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|